Literature DB >> 11575293

Bone loss accompanying medical therapies.

B Dawson-Hughes.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11575293     DOI： 10.1056/NEJM200109273451310

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].

Authors:  K Heine; J M Wolff
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

Review 2.  [Therapy of hormone-refractory prostate cancer].

Authors:  A Heidenreich
Journal:  Urologe A       Date:  2005-12       Impact factor: 0.639

Review 3.  [Treatment options for hormone-refractory prostate cancer].

Authors:  A Heidenreich; C H Ohlmann
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

4.  New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.

Authors:  Mone Zaidi; Harry C Blair; Jameel Iqbal; Terry F Davies; Ling Ling Zhu; Alberta Zallone; Li Sun
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

5.  Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma.

Authors:  John H Toogood
Journal:  Allergy Asthma Clin Immunol       Date:  2005-03-15       Impact factor: 3.406
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.